FDA Wouldn't Get Funding Boost As Part Of Senate GOP Innovation Bill
This article was originally published in The Pink Sheet Daily
Executive Summary
Sen. Alexander says FDA should receive gradual appropriations increases, rather than part of "surge" in funding proposed for NIH.
You may also be interested in...
Priority Review Voucher Program For Rare Pediatric Diseases Extended As FDA Lowers Fee
Next fiscal year will be a good one to redeem a voucher, and probably to qualify for one as well.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.
Parallel Scientific Advice: Is The EMA User Fee Impacting Interest?
EMA charges participants to receive scientific advice through the fledgling program, unlike the US FDA, which may not fit the budgets of some complex generic sponsors. At the same time, sponsors also may simply not be aware the program exists yet.